Optimum Investment Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13.2K Buy
135
+45
+50% +$3.62K 0.01% 484
2025
Q2
$6.27K Hold
90
﹤0.01% 533
2025
Q1
$4.47K Sell
90
-50
-36% -$3.16K ﹤0.01% 567
2024
Q4
$9.78K Hold
140
﹤0.01% 510
2024
Q3
$14.7K Hold
140
0.01% 489
2024
Q2
$19.9K Sell
140
-50
-26% -$5.76K 0.01% 448
2024
Q1
$21.2K Buy
190
+140
+280% +$16.7K 0.01% 451
2023
Q4
$6.49K Hold
50
﹤0.01% 544
2023
Q3
$8.15K Buy
+50
New +$8.79K ﹤0.01% 563
2023
Q2
Sell
-250
Closed -$33.3K 714
2023
Q1
$33.3K Sell
250
-1,250
-83% -$147K 0.02% 421
2022
Q4
$119K Sell
1,500
-546
-27% -$38.5K 0.06% 240
2022
Q3
$124K Buy
2,046
+300
+17% +$19.4K 0.07% 239
2022
Q2
$96K Sell
1,746
-600
-26% -$34.8K 0.05% 290
2022
Q1
$177K Buy
+2,346
New +$160K 0.07% 228

Other funds holding ACLS

Optimum Investment Advisors's ACLS Position: Q3 2025 in Review

Optimum Investment Advisors increased its Axcelis (ACLS) stake by 50% in Q3 2025, buying an estimated $3.62K and bringing the position to 135 shares worth $13.2K. The position accounts for 0.01% of the portfolio, ranked #484.

Optimum Investment Advisors first reported a position in ACLS in Q1 2022 and has held it in 14 quarters since. The position peaked at $177K in Q1 2022. 360 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.

  • Optimum Investment Advisors held 135 shares of Axcelis worth $13.2K as of Q3 2025.
  • Optimum Investment Advisors bought 45 Axcelis shares in Q3 2025, an estimated $3.62K.
  • Axcelis made up 0.01% of Optimum Investment Advisors's portfolio in Q3 2025, its #484 holding.
  • Optimum Investment Advisors first reported a position in Axcelis in Q1 2022 and has held it in 14 quarters since.
  • Optimum Investment Advisors's Axcelis position peaked at $177K in Q1 2022.
  • 360 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.